- Enhanced Glucose Control: Improves blood sugar levels by reducing both fasting and postprandial (after-meal) glucose concentrations.
- Weight Loss: Clinically shown to reduce body weight through decreased food intake and appetite suppression.
- Dual Receptor Action: Targets both GIP and GLP-1 receptors, offering a more comprehensive approach to managing diabetes and weight loss.
- Improved Pancreatic Function: Stimulates insulin release in a glucose-dependent manner, enhancing the body’s natural response to high blood sugar.
- Reduced Appetite: Helps patients feel fuller for longer, reducing overall calorie intake.
- Potential for Cardiovascular Benefits: Some studies suggest potential cardiovascular benefits, though more research is needed for conclusive evidence.
- Versatility in Treatment: Can be used effectively in the management of type 2 diabetes and has potential for weight management in non-diabetics.
- Positive Impact on Body Mass Index (BMI): Demonstrates efficacy in reducing BMI, an important marker for overall health.










